Differential regulation of adapter proteins Dok2 and Dok1 in platelets, leading to an association of Dok2 with integrin αIIbβ3

Journal of Thrombosis and Haemostasis

Volumn 5, Issue 2, 2007, Pages 387-394

  Hughan, Sascha C ^a,b   Watson, S P ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Dok2; Integrin IIb 3; Platelets

Indexed keywords

ADAPTOR PROTEIN; ALPHA2 INTEGRIN; ALPHA2BBETA3 INTEGRIN; CALCIUM; GLYCOPROTEIN VI; PHOSPHOLIPASE C GAMMA2; PROTEIN DOK1; PROTEIN DOK2; PROTEIN KINASE SYK; PROTEIN TYROSINE KINASE INHIBITOR; THROMBIN; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM CELL LEVEL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWNSTREAM PROCESSING; GENE CONTROL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THROMBOCYTE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BLOOD PLATELETS; DNA-BINDING PROTEINS; HUMANS; MICE; MICE, KNOCKOUT; PHOSPHOPROTEINS; PHOSPHORYLATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION;

EID: 33846419172     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02307.x     Document Type: Article

References (36)

1. Leo A, Schraven B. Networks in signal transduction: The role of adaptor proteins in platelet activation. Platelets 2000; 11: 429-45.
2. Garcia A, Prabhakar S, Hughan S, Anderson TW, Brock CJ, Pearce AC, Dwek RA, Watson SP, Hebestreit HF, Zitzmann N. Differential proteome analysis of TRAP-activated platelets: Involvement of DOK-2 and phosphorylation of RGS proteins. Blood 2004; 103: 2088-95.
3. Di Cristofano A, Carpino N, Dunant N, Friedland G, Kobayashi R, Strife A, Wisniewski D, Clarkson B, Pandolfi PP, Resh MD. Molecular cloning and characterization of p56dok-2 defines a new family of RasGAP-binding proteins. J Biol Chem 1998; 273: 4827-30.
4. Carpino N, Wisniewski D, Strife A, Marshak D, Kobayashi R, Stillman B, Clarkson B. p62(dok): A constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell 1997; 88: 197-204.
5. Sattler M, Verma S, Pride YB, Salgia R, Rohrschneider LR, Griffin JD. SHIP1, an SH2 domain containing polyinositol-5-phosphatase, regulates migration through two critical tyrosine residues and forms a novel signaling complex with DOK1 and CRKL. J Biol Chem 2001; 276: 2451-8.
6. Robson JD, Davidson D, Veillette A. Inhibition of the Jun N-terminal protein kinase pathway by SHIP-1, a lipid phosphatase that interacts with the adaptor molecule Dok-3. Mol Cell Biol 2004; 24: 2332-43.
7. Lemay S, Davidson D, Latour S, Veillette A. Dok-3, a novel adapter molecule involved in the negative regulation of immunoreceptor signaling. Mol Cell Biol 2000; 20: 2743-54.
8. Liang X, Wisniewski D, Strife A, Shivakrupa, Clarkson B, Resh MD. Phosphatidylinositol 3-kinase and Src family kinases are required for phosphorylation and membrane recruitment of Dok-1 in c-Kit signaling. J Biol Chem 2002; 277: 13732-8.
9. Calderwood DA, Fujioka Y, de Pereda JM, Garcia-Alvarez B, Nakamoto T, Margolis B, McGlade CJ, Liddington RC, Ginsberg MH. Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains: A structural prototype for diversity in integrin signaling. Proc Natl Acad Sci USA 2003; 100: 2272-7.
10. Niki M, Di Cristofano A, Zhao M, Honda H, Hirai H, Van Aelst L, Cordon-Cardo C, Pandolfi PP. Role of Dok-1 and Dok-2 in leukemia suppression. J Exp Med 2004; 200: 1689-95.
11. Yasuda T, Shirakata M, Iwama A, Ishii A, Ebihara Y, Osawa M, Honda K, Shinohara H, Sudo K, Tsuji K, Nakauchi H, Iwakura Y, Hirai H, Oda H, Yamamoto T, Yamanashi Y. Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia. J Exp Med 2004; 200: 1681-7.
12. Woodring PJ, Meisenhelder J, Johnson SA, Zhou GL, Field J, Shah K, Bladt F, Pawson T, Niki M, Pandolfi PP, Wang JY, Hunter T. c-Abl phosphorylates Dok1 to promote filopodia during cell spreading. J Cell Biol 2004; 165: 493-503.
13. Gerard A, Favre C, Garcon F, Nemorin JG, Duplay P, Pastor S, Collette Y, Olive D, Nunes JA. Functional interaction of RasGAP-binding proteins Dok-1 and Dok-2 with the Tec protein tyrosine kinase. Oncogene 2004; 23: 1594-8.
14. Noguchi T, Matozaki T, Inagaki K, Tsuda M, Fukunaga K, Kitamura Y, Kitamura T, Shii K, Yamanashi Y, Kasuga M. Tyrosine phosphorylation of p62(Dok) induced by cell adhesion and insulin: Possible role in cell migration. EMBO J 1999; 18: 1748-60.
15. Di Cristofano A, Niki M, Zhao M, Karnell FG, Clarkson B, Pear WS, Van Aelst L, Pandolfi PP. p62(dok), a negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210(bcr-abl). J Exp Med 2001; 194: 275-84.
16. Wonerow P, Pearce AC, Vaux DJ, Watson SP. A critical role for phospholipase Cγ2 in αIIbβ3-mediated platelet spreading. J Biol Chem 2003; 278: 37520-9.
17. McCarty OJ, Zhao Y, Andrew N, Machesky LM, Staunton D, Frampton J, Watson SP. Evaluation of the role of platelet integrins in fibronectin-dependent spreading and adhesion. J Thromb Haemost 2004; 2: 1823-33.
18. Hughan SC, Senis Y, Best D, Thomas A, Frampton J, Vyas P, Watson SP. Selective impairment of platelet activation to collagen in the absence of GATA1. Blood 2005; 105: 4369-76.
19. Suzuki-Inoue K, Inoue O, Frampton J, Watson SP. Murine GPVI stimulates weak integrin activation in PLCgamma2-/- platelets: Involvement of PLCgamma1 and PI3-kinase. Blood 2003; 102: 1367-73.
20. Wang D, Feng J, Wen R, Marine J-C, Sangster MY, Parganas E, Hoffmeyer A, Jackson CW, Cleveland JL, Murray PJ, Ihle JN. Phospholipase C [gamma]2 is essential in the functions of B cell and several Fc receptors. Immunity 2000; 13: 25-35.
21. Mocsai A, Zhou M, Meng F, Tybulewicz VL, Lowell CA. Syk is required for integrin signaling in neutrophils. Immunity 2002; 16: 547-58.
22. Goncalves I, Nesbitt WS, Yuan Y, Jackson SP. Importance of temporal flow gradients and integrin alphaIIbbeta3 mechanotransduction for shear activation of platelets. J Biol Chem 2005; 280: 15430-7.
23. Garcia A, Senis YA, Antrobus R, Hughes CE, Dwek RA, Watson SP, Zitzmann N. A global proteomics approach identifies novel phosphorylated signaling proteins in GPVI-activated platelets: Involvement of G6f, a novel platelet Grb2-binding membrane adapter. Proteomics 2006; 6: 5332-43.
24. Nemorin JG, Duplay P. Evidence that Lck-mediated phosphorylation of p56dok and p62dok may play a role in CD2 signaling. J Biol Chem 2000; 275: 14590-7.
25. Obergfell A, Eto K, Mocsai A, Buensuceso C, Moores SL, Brugge JS, Lowell CA, Shattil SJ. Coordinate interactions of Csk, Src, and Syk kinases with [alpha]IIb [beta]3 initiate integrin signaling to the cytoskeleton. J Cell Biol 2002; 157: 265-75.
26. Goncalves I, Hughan SC, Schoenwaelder SM, Yap CL, Yuan Y, Jackson SP. Integrin αIIbβ3-dependent calcium signals regulate platelet-fibrinogen interactions under flow: Involvement of phospholipase Cγ2. J Biol Chem 2003; 278: 34812-22.
27. Lock P, Casagranda F, Dunn AR. Independent SH2-binding sites mediate interaction of Dok-related protein with RasGTPase-activating protein and Nck. J Biol Chem 1999; 274: 22775-84.
28. Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ, Pollok BA, Connelly PA. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J Biol Chem 1996; 271: 695-701.
29. Quek LS, Pasquet JM, Hers I, Cornall R, Knight G, Barnes M, Hibbs ML, Dunn AR, Lowell CA, Watson SP. Fyn and Lyn phosphorylate the Fc receptor gamma chain downstream of glycoprotein VI in murine platelets, and Lyn regulates a novel feedback pathway. Blood 2000; 96: 4246-53.
30. Gao J, Zoller KE, Ginsberg MH, Brugge JS, Shattil SJ. Regulation of the pp72syk protein tyrosine kinase by platelet integrin alpha IIb beta 3. EMBO J 1997; 16: 6414-25.
31. Watson SP, Auger JM, McCarty OJT, Pearce AC. GPVI and integrin αIIbβ3 signaling in platelets. J Thromb Haemost 2005; 3: 1752-62.
32. Atkinson BT, Stafford MJ, Pears CJ, Watson SP. Signalling events underlying platelet aggregation induced by the glycoprotein VI agonist convulxin. Eur J Biochem 2001; 268: 5242-8.
33. Atkinson BT, Jarvis GE, Watson SP. Activation of GPVI by collagen is regulated by alpha2beta1 and secondary mediators. J Thromb Haemost 2003; 1: 1278-87.
34. Cai D, Dhe-Paganon S, Melendez PA, Lee J, Shoelson SE. Two new substrates in insulin signaling, IRS5/DOK4 and IRS6/DOK5. J Biol Chem 2003; 278: 25323-30.
35. Phillips DR, Nannizzi-Alaimo L, Prasad KS. Beta3 tyrosine phosphorylation in alphaIIbbeta3 (platelet membrane GP IIb-IIIa) outside-in integrin signaling. Thromb Haemost 2001; 86: 246-58.
36. Yamanashi Y, Tamura T, Kanamori T, Yamane H, Nariuchi H, Yamamoto T, Baltimore D. Role of the rasGAP-associated docking protein p62(dok) in negative regulation of B cell receptor-mediated signaling. Genes Dev 2000; 14: 11-6.